Intrathecal chemotherapy for refractory disseminated medulloblastoma

Child's Nervous System

Volumn 24, Issue 5, 2008, Pages 581-585

  Yoshimura, Junichi ^a   Nishiyama, Kenichi ^a   Mori, Hiroshi ^b   Takahashi, Hideaki ^a   Fujii, Yukihiko ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dissemination; Intrathecal(IT) chemotherapy; MCNU); Medulloblastoma; Methotrexate; Nitrosourea(ACNU; Ventriculolumbar perfusion chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; NIMUSTINE; NITROSOUREA DERIVATIVE; RANIMUSTINE;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; BOLUS INJECTION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED CANCER; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCONTINENCE; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARAPLEGIA; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MEDULLOBLASTOMA; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; NIMUSTINE; NITROSOUREA COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 42449083348     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-007-0538-8     Document Type: Article

References (11)

1. Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ, Klenke R, Berg SL, Blaney SM (2004) Phase II trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22:3916-3921
2. Edwards MS, Levine VA, Seager ML, Wilson CB (1981) Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma. Child Brain 8:444-451
3. Kochi M, Kuratsu J, Mihara Y, Takaki S, Seto H, Uemura S, Ushio Y (1993) Ventriculolumbar perfusion of
4. Morikawa N, Mori T, Kawashima H, Takeyama M, Abe T, Kobayashi H (2001) Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid perfusion chemotherapy. Biol Pharm Bull 24:436-438
5. Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P, Ricardi R (2001) Intrathecal chemotherapy with antineoplastic agent in children. Paediatr Drugs 3:237-246
6. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolf JEA, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986
7. Salvac I, Shuller E, Czech T, Hainfellner JA, Seidl R, Dieckmann K (1998) Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination. J Neurooncol 38:213-218
8. Shapiro WR (1975) Chemotherapy of primary malignant brain tumors in children. Cancer 35:965-972
9. Shapiro WR, Young DF, Mehta B (1975) Methotrexate: Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161-166
10. Ushio U, Kochi M, Kitamura I, Kuratsu J (1998) Ventriculolumbar perfusion of
11. Yoshida S, Morii K (2005) Intrathecal chemotherapy for patients with meningeal carcinomatosis. Surg Neurol 63:52-55